Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06452771
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-06-05
Brief Title:
A First In Human FIH Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults
Sponsor:
Regeneron Pharmaceuticals
Organization:
Regeneron Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-15
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-05
First Submit QC Date:
June 5 2024
Study First Post Date:
2024-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-13
Last Update Post Date:
2024-07-10
Last Update Post Date Type:
ACTUAL